Weidentified 11,301 RASI-related adverse events (AEs) of hyperkalemia and AKI inthe FAERS database; 4997 were due to Angiotensin-converting enzyme inhibitors (ACEIs),5658 were due to angiotensin receptor blockers (ARBs), and 646 weredue to the combination of ACEI and ARB. Here, ACE is linked to Hyperkalemia.